An interdisciplinary team of engineers and pharmaceutical researchers at the University of Alberta has invented a device that can rapidly identify harmful bacteria and can determine whether it is resistant to antibiotics.
The device could save precious hours in patient care and public health, and prevent the spread of drug-resistant strains of bacteria.
The team's findings can help in detecting bacteria and measure their susceptibility to antibiotics in small confined volumes.
The device was designed to look for and trap different types of bacteria and find out which antibiotics are most effective against them.
Rather than growing bacterial cultures then testing them, the microscopic device relies on nano-scale technology for fast results.
The main feature of the device is a cantilever, a plank that resembles a diving board that has a microfluidic channel 25 times smaller than the width of a hair etched on its surface.
The channel is coated with biomaterials, like antibodies, that harmful bacteria like E. coli or Listeria in fluid samples stick to.
When bacteria are caught, the device sends out three different signals to the researchers.
When bacteria is detected the cantilever's mass changes, and it bends, explained researcher Thomas Thundat.
"So, this gives us two signals: the mass change and the bending action by shining infrared light on the bacteria, a third signal is sent, he added. If the bacterial absorbs the light it begins to vibrate, generating a minute amount of heat that sends a confirmation signal.
Having three detection methods means there is no ambiguity, he said.
"By monitoring the interaction of light and bacteria, we can get highly selective detection of bacteria," said Faheem Khan, another expert.
With the bacteria trapped in the cantilever, different antibiotic drugs can be added to the device.
Changes in the intensity of tiny oscillations of the cantilever signal will inform the researchers whether the bacteria are alive or dead.
The researchers then know which antibiotics the bacteria are susceptible to.
"We're trying to find a way to fight bacterial resistance to drugs and prevent or at least decrease the spread of drug-resistant strains,"
said Hashem Etayash, a researcher.
Adding, "We're able to do several tests in a very short period of time and we can quickly identify bugs that can resist antibiotics."
The device can be used to test extremely small fluid samples, millions of times smaller than a rain droplet.
The size of the device is advantageous when you only want a very small sample, in settings such as a neonatal intensive care unit, or in
situations where only very small samples are available.
The research was published in Nature Communications journal.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
